Related Experiment Video
Updated: Jun 13, 2026
Biochemical Measurement of Neonatal Hypoxia
Published on: August 24, 2011
Evaluation of Home Phototherapy for Neonatal Hyperbilirubinemia
Pearl W Chang1, Whitney M Waite2
1Department of Pediatrics, Seattle Children's Hospital, Seattle, WA; Department of Pediatrics, University of Washington, Seattle, WA.
Insights
Home phototherapy effectively treats neonatal hyperbilirubinemia in most infants. Younger age at treatment initiation and higher bilirubin levels increased the risk of hospital admission.
Area of Science:
- Neonatal care
- Pediatric gastroenterology
- Public health
Background:
- Neonatal hyperbilirubinemia is a common condition requiring treatment.
- Home phototherapy offers a convenient alternative to hospitalization for managing jaundice.
- Assessing risk factors for treatment failure is crucial for optimizing care.
Purpose of the Study:
- To evaluate the effectiveness of home phototherapy for neonatal hyperbilirubinemia.
- To identify risk factors associated with hospital admission during or after home phototherapy.
Main Methods:
- Retrospective study of 1324 infants undergoing home phototherapy.
- Inclusion criteria: infants born at ≥35 weeks gestation, treated within 14 days, with specific bilirubin levels.
- Logistic regression analysis to determine risk factors for hospitalization.
Main Results:
- Home phototherapy successfully treated hyperbilirubinemia in the majority of infants.
- 1.9% of infants required hospitalization.
- Younger age at initiation and higher bilirubin levels relative to the phototherapy threshold were associated with increased hospitalization risk.
Conclusions:
- Comprehensive home phototherapy is a successful treatment for neonatal hyperbilirubinemia for most infants.
- Early initiation and closer monitoring of infants with higher bilirubin levels may reduce hospital admissions.
Objective:
To characterize home phototherapy treatment for neonatal hyperbilirubinemia and assess the risk factors associated with the need for hospital admission during or after home phototherapy.
Study Design:
This was a retrospective study of newborn infants born at ≥35 weeks of gestation who underwent comprehensive home phototherapy (that included daily in-home lactation support and blood draws) over an 18-month period. We excluded infants who lacked a recorded birth date or time, started treatment at age >14 days, or had a conjugated serum bilirubin level of ≥2 mg/dL (≥34.2 μmol/L). The primary study outcome was any hospital admission during or within 24 hours after completion of home phototherapy. Logistic regression was used to identify risk factors for hospitalization.
Results:
Of the cohort of 1385 infants, 1324 met the inclusion criteria. At the time home phototherapy was initiated, 376 infants (28%) were at or above the American Academy of Pediatrics phototherapy threshold. Twenty-five infants required hospitalization (1.9%; 95% CI, 1.3%-2.8%). Hospital admission was associated with a younger age at phototherapy initiation (OR, 0.63 for each day older in age; 95% CI, 0.44-0.91) and a higher total serum bilirubin level relative to the treatment threshold at phototherapy initiation (OR, 1.71 for each 1 mg/dL above the treatment threshold; 95% CI, 1.40-2.08).
Conclusions:
Comprehensive home phototherapy successfully treated hyperbilirubinemia in the vast majority of the infants in this cohort.
